The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms
Abstract
Ketamine, a novel treatment for depression, has generated considerable interest and research. Few experiments address lay impressions of the credibility of ketamine treatment relative to another popular intervention for depression, CBT. Over 500 participants with depressive symptoms read descriptions of CBT, ketamine, and a treatment that combined the two. Descriptions included pros and cons of each approach. Participants found the combination treatment more credible than ketamine but no better than CBT alone. They rated the credibility of CBT alone significantly higher than ketamine alone. Participants with psychotherapy experience tended to view ketamine as less credible than those who did not report previous psychotherapy. Depression scores did not covary with credibility ratings for any treatment. Despite media coverage and Internet claims, potential clients are cautious about ketamine. These results suggest that providing descriptions of treatments might help reveal important information about their credibility to potential clients. Extended work assessing impressions of many approaches to the treatment of psychopathology and other problems appears justifiable. Given established links between credibility and treatment outcome, additional research on individual differences in perceptions of ketamine and varied treatments for depression seems warranted. © 2021 Taylor & Francis Group, LLC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403 · cited 2×
“We administered The Center for Epidemiologic Studies Depression Scale Revised (CESD-R–10) to measure depression (Andresen et al. 1994).”
MethodAndresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426
Identifying careless responses in survey data.
Meade, A. W., & Craig, S. B. (2012) · Psychological Methods · doi:10.1037/a0028085 · Cited by 3,865 · cited 1×
“Previous work suggests that these approaches can decrease error variance and improve correlations among indicators of the same construct (Meade and Craig 2012).”
BackgroundHow Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory
Graham, J. W., Olchowski, A. E., & Gilreath, T. D. (2007) · Prevention Science · doi:10.1007/s11121-007-0070-9 · Cited by 2,795 · cited 1×
“A classic estimate suggests costs in the US surpassed $210 billion per year (Greenberg et al. 2015), but the data are from 2010.”
BackgroundPsychometric properties of the credibility/expectancy questionnaire
Devilly, G. J., & Borkovec, T. D. (2000) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(00)00012-4 · Cited by 2,295
Flexible Imputation of Missing Data, Second Edition
van Buuren, S. (2018) · doi:10.1201/9780429492259 · Cited by 2,273
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · cited 1×
“…work to other psychedelic-assisted therapies, including ayahuasca (Palhano-Fontes et al. 2019), MDMA (Vermetten and Yehuda 2020), and psilocybin (Carhart-Harris et al. 2016) for depression, might illuminate the credibility of these alternative treatments for depression and other refractory…”
BackgroundLiu, Q., He, H., Yang, J., Feng, X., Zhao, F., & Lyu, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.002 · Cited by 1,452
Research works printed but not linked: 2
- Huang E. C. H., 2018, INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 55
- Bureau, 2020, “CPI inflation calculator“. Accessed
Cited by
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?
Earleywine, M., Low, F., Altman, B. R., & Leo, J. A. D. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2047842 · Cited by 34
Self-citationFeng, W., Chen, C., Zeng, Y., & Zhang, B. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111152 · Cited by 11
Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions
McCartney, A., McGovern, H. T., & Foe, A. D. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00211 · Cited by 13
Tamman, A. J. F., Anand, A., & Mathew, S. J. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2049754 · Cited by 6
“credibility of the treatment may be limited compared to psychotherapy, according to one study [185], an important con-”
ResultExpectancies for Subjective and Antidepressant Effects in Psilocybin Users
Earleywine, M., Mian, M. N., & Leo, J. A. D. (2023) · Journal of Humanistic Psychology · doi:10.1177/00221678231194798 · Cited by 6
Self-citation
Metadata
- Authors
- Earleywine, M., Altman, B. R., & De Leo, J.
- Affiliations
- State University of New York (US)
- Centre for Compassionate Care, Hamilton, Ontario, Canada
- Corresponding author
- Earleywine, Mitch
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2021-04-20
- Volume
- 54
- Issue
- 1
- Pages
- 70-80
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W3155481108
- Cited by
- 9
- References
- 57
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 4
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychoactive Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- ketamine, cognitive behavioral therapy, depression, treatment credibility, combination therapy, psychotherapy experience
- MeSH terms
- Depression, Humans, Ketamine, Psychotherapy, Cognitive Behavioral Therapy, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms. https://app.cochat.ai/papers/10.1080/02791072.2021.1912863
- The paper
- Earleywine, M., Altman, B. R., & De Leo, J. (2022). Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2021.1912863
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.